It started with a kit

It started with a kit Spun-off from Düsseldorf University almost 25 years ago, Qiagen has become the world's leading provider of sample technologies and a top player in molecular diagnostics. By Claudia Eberhard-Metzger Device production at Qiagen: The assembly of prefabricated components into Qiagen spin columns that are used for sample preparation. The machine can produce up to five million spin columns a year. © Jens Willebrand

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

By Claudia Eberhard-Metzger

"What you need is something you can throw away!"

At first thought, such a statement seems an unlikely premise to model a successful company on. It was the summer of 1986, and the advice was given to a young European scientist with a good idea but little experience of market requirements. It came from Michael Hunkapiller, head of research at the California firm Applied Biosystems, and it turned out to be absolutely spot-on.

The young scientist, Metin Colpan, took the counsel of his experienced colleague to heart. On the flight back to Germany he began revising his ideas for a new product. Colpan's idea was to place the materials needed for isolating and purifying nucleic acids into small plastic vessels instead of the stainless steel columns that were currently used. Miniaturization might solve all the problems besetting the nucleic acid isolation and purification in one go. A ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Claudia Eberhard-Metzger

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide